✓ Medically Reviewed Monograph

Levosalbutamol

Also known as / Synonyms: Levalbuterol, R-Salbutamol, Pure R-enantiomer SABA

Single-isomer short-acting beta-2 agonist (SABA) that rapidly relieves acute asthma and COPD bronchospasm with lower heart palpitation risk.

Medically reviewed by Dr. Lisa Matthews, PharmD BCPS · Clinical Pharmacist
Written by 4mg Clinical Pharmacology Team Last reviewed ✓ Clinically Verified
📋

Clinical Snapshot & Specifications

Generic Name: Levosalbutamol
Active Ingredient: Levosalbutamol Sulphate
Dosage Form: Inhaler
Available Strengths: 50 mcg/actuation MDI inhaler; 0.31 mg, 0.63 mg, 1.25 mg respules for nebulization; 1 mg, 2 mg tablets
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Inhaled Oral
Popular Verified Brands:
Levolin Xopenex Aerolin-L (India)
Regulatory Standards: CDSCO approved; Schedule H prescription drug in India. US FDA approved as levalbuterol.
🎯

Approved Indications & Medical Uses

  • Treatment or prevention of acute bronchospasm in adults and children 4 years of age and older with reversible obstructive airway disease (asthma, COPD).
  • Preferred over racemic salbutamol in patients prone to beta-agonist-induced tachycardia, cardiac palpitations, or tremors due to omission of the (S)-isomer.
🚫

Contraindications (Do Not Use If…)

  • History of hypersensitivity to levosalbutamol, racemic salbutamol, or any excipients.
  • Used for tocolysis in threatened abortion or premature labor.
🛡️

Important Clinical Precautions & Warnings

  • Paradoxical bronchospasm: can occur and may be life-threatening; discontinue immediately and institute alternative therapy.
  • Cardiovascular effects: can produce clinically significant tachycardia, blood pressure changes, and palpitations, although less frequently than racemic salbutamol.
  • Hypokalemia and hyperglycemia: can produce transient reductions in serum potassium and elevations in blood glucose.
  • Excessive use: deterioration of asthma requires reassessment of maintenance therapy (e.g., intensifying inhaled corticosteroids), not continuous escalation of bronchodilators.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Approved for nebulization in children >= 4 years. Dosing in infants must be carefully supervised. Geriatric: Start at lower recommended doses due to higher prevalence of underlying cardiovascular disease.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Fine skeletal muscle tremor, nervousness, headache, dizziness, tachycardia, palpitations, throat irritation, and nausea.

🚨 Serious Side Effects — Seek Urgent Medical Care

Severe paradoxical bronchospasm, cardiac arrhythmias, myocardial ischemia, significant hypokalemia, and immediate hypersensitivity reactions (urticaria, angioedema).

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Non-cardioselective beta-blockers (propranolol): block bronchodilator effect and can produce severe bronchospasm in patients with asthma.
  • Potassium-depleting diuretics: co-administration can potentiate acute hypokalemia.
  • Digoxin: may produce modest decreases in serum digoxin levels; monitor digitalis concentrations.
  • MAO inhibitors and tricyclic antidepressants: potentiate cardiovascular actions on vascular tone.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

Clinical data on levalbuterol in pregnant women are limited. Albuterol has extensive human experience without evidence of teratogenicity. It should be used during pregnancy only if the potential benefit justifies potential fetal risk.

Lactation & Breastfeeding:

Use with caution — see notes

It is not known whether levosalbutamol is excreted in human milk. Exercise caution when administering to a nursing woman.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store MDI canister at 20°C to 25°C (68°F to 77°F). Do not puncture or incinerate pressurized canister. Store nebulizer respules in original foil pouch to protect from light.

⏱️ Missed Dose Protocol:

Take as needed for acute shortness of breath. If prescribed on a scheduled regimen, take as soon as remembered unless close to the next dose. Never double puff.

📚

Clinical Sources & Regulatory References

Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.

Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:

🏛️ CDSCO (Govt. of India)

Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).

CDSCO Official Portal →
🇺🇸 U.S. FDA / DailyMed

U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.

Search FDA Labels on DailyMed →
🌐 World Health Organization

WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).

WHO Essential Medicines Registry →
🔬 PubMed / NLM

National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.

Query PubMed Studies for Levosalbutamol →
Suggested Monograph Citation:

4mg Clinical Pharmacology Team. Levosalbutamol Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/levosalbutamol/

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.